AI
Sunday, June 08, 2025 11:40:34 AM
Thanks for posting this hyperopia.
You are correct that this new improved version of Flaskworks Eden system is not about manufacturing CAR-T cells. It is completely about manufacturing adherent dendritic cell therapies, like DCVax-L and DCVax Direct.
This new improved system will produce a greater yield of dendritic cells, and the dendritic cells will be more potent, have increased purity, and less impurities.
This new device can be configured with multiple bioreactors, and will allow for significantly greater global manufacturing scale capacity. This will truly allow the DCVax dendritic cell vaccine platform to scale to treat all or most solid tumor cancers in the future.
You are correct that this new improved version of Flaskworks Eden system is not about manufacturing CAR-T cells. It is completely about manufacturing adherent dendritic cell therapies, like DCVax-L and DCVax Direct.
This new improved system will produce a greater yield of dendritic cells, and the dendritic cells will be more potent, have increased purity, and less impurities.
This new device can be configured with multiple bioreactors, and will allow for significantly greater global manufacturing scale capacity. This will truly allow the DCVax dendritic cell vaccine platform to scale to treat all or most solid tumor cancers in the future.
Bullish
This is a PSA to all manipulative and collusive Market Makers, Hedge Funds and Short Sellers:
TIME IS RUNNING OUT. THE CLOCK IS TICKING!!!
